Stansberry Research

U.S. Midday Stock Moves: TPTX, CVGW, OKTA, HCP, JOAN

Daniel SmootStansberry NewsWire


  • Turning Point Therapeutics (TPTX) +116.5%. TPTX will be acquired by Bristol-Myers Squibb (BMY) for $4.1 billion.
  • Calavo Growers (CVGW) +13%. CVGW's second-quarter earnings and revenue came in above estimates.
  • Okta (OKTA) +7.9%. OKTA's first-quarter revenue, billings, and operating income were stronger than anticipated.


  • HashiCorp (HCP) -22%. Analysts were focused on a slight deceleration in HCP's growth.
  • JOANN (JOAN) -20.1%. JOAN's first-quarter earnings, margins, and comparable-store sales disappointed.